methyl 5-aminolevulinate has been researched along with Kaposi Sarcoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alcantara-Nicolas, F; Canseco-Martin, M; Fernandez-Gonzalez, P; Fonda-Pascual, P; Lopez-Galan, C; Sanchez-Los Arcos, L; Vidal-Asensi, S | 1 |
1 other study(ies) available for methyl 5-aminolevulinate and Kaposi Sarcoma
| Article | Year |
|---|---|
Treatment of cutaneous Kaposi sarcoma with methylaminolevulinate photodynamic therapy: A case series.
Topics: Adult; Aged, 80 and over; Aminolevulinic Acid; Humans; Male; Photochemotherapy; Photosensitizing Agents; Sarcoma, Kaposi; Skin Neoplasms | 2020 |